• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Perinat Med . Effect of SARS-CoV-2 infection on fetal umbilical vein flow and cardiac function: a prospective study

tetano

Editor, Senior Moderator
J Perinat Med


. 2022 Jan 21.
doi: 10.1515/jpm-2021-0657. Online ahead of print.
Effect of SARS-CoV-2 infection on fetal umbilical vein flow and cardiac function: a prospective study


Giuseppe Rizzo[SUP] 1 2 [/SUP], Ilenia Mappa[SUP] 1 [/SUP], Maria Elena Pietrolucci[SUP] 1 [/SUP], Jia Li Angela Lu[SUP] 1 [/SUP], Alexander Makatsarya[SUP] 2 [/SUP], Francesco D'Antonio[SUP] 3 [/SUP]



Affiliations

Abstract

Objectives: To explore whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can affect umbilical vein blood flow (UVBF) and fetal cardiac function.
Methods: Prospective case-control study of consecutive pregnancies complicated by SARS-CoV-2 infection during the second half of pregnancy matched with unaffected women. Measurements of UVBF normalized for fetal abdominal circumference (UVBF/AC), atrial area (AA) and ventricular sphericity indices (SI) were compared between the two study groups. Chi-square and Mann-Whitney U tests were sued to analyze the data.
Results: Fifty-four consecutive pregnancies complicated and 108 not complicated by SARS-CoV-2 infection were included. The median gestational age at infection was 30.2 (interquartile range [IQR] 26.2 34.1). General baseline and pregnancy characteristics were similar between pregnant women with compared to those without SARS-CoV-2 infection. There was no difference in UVBF/AC (study groups z value -0.11 vs. 0.14 control p 0.751) values between pregnancies complicated compared to those not complicated by SARS-CoV-2 infection. Likewise, there was no difference in the left and right AA (left 1.30 vs. 1.28 p=0.221 and right 1.33 vs. 1.31 p=0.324) and SI (left 1.75 vs. 1.77 p=0.208 and right 1.51 vs. 1.54 p=0.121) between the two groups.
Conclusions: SARS-CoV-2 infection does not affect UVBF and fetal cardiac function in uncomplicated pregnancies.

Keywords: COVID-19; fetal cardiac function; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection; umbilical vein flow.
 
Back
Top Bottom